Impakter
  • Environment
    • Biodiversity
    • Climate Change
    • Circular Economy
    • Energy
  • FINANCE
    • ESG News
    • Sustainable Finance
    • Business
  • TECH
    • Start-up
    • AI & Machine Learning
    • Green Tech
  • Industry News
    • Entertainment
    • Food and Agriculture
    • Health
    • Politics & Foreign Affairs
    • Philanthropy
    • Science
    • Sport
  • Editorial Series
    • SDGs Series
    • Shape Your Future
    • Sustainable Cities
      • Copenhagen
      • San Francisco
      • Seattle
      • Sydney
  • About us
    • Our Story
    • Team
    • Partners
    • Write for Impakter
    • Contact Us
    • Privacy Policy
No Result
View All Result
  • Environment
    • Biodiversity
    • Climate Change
    • Circular Economy
    • Energy
  • FINANCE
    • ESG News
    • Sustainable Finance
    • Business
  • TECH
    • Start-up
    • AI & Machine Learning
    • Green Tech
  • Industry News
    • Entertainment
    • Food and Agriculture
    • Health
    • Politics & Foreign Affairs
    • Philanthropy
    • Science
    • Sport
  • Editorial Series
    • SDGs Series
    • Shape Your Future
    • Sustainable Cities
      • Copenhagen
      • San Francisco
      • Seattle
      • Sydney
  • About us
    • Our Story
    • Team
    • Partners
    • Write for Impakter
    • Contact Us
    • Privacy Policy
No Result
View All Result
Impakter
No Result
View All Result

Monkeypox Now Declared a “National Health Emergency” in the US. Should Have This Been Done Sooner?

What are the consequences of this decision? Was this (again) a slow response to a very dangerous virus?

byAlessandro du Besse' - Tech Editor
August 8, 2022
in Health, Society

Last Thursday the Biden administration declared Monkeypox a Public Health Emergency in the US. This follows a similar declaration by the WHO that two weeks ago labeled monkeypox a Global Health Emergency. Was this a late decision? Has the US failed to contain (again) a dangerous virus?

First of all, the good news. Monkeypox rarely leads to death. So far only eight people died from the current monkeypox outbreak. Most of the deaths happened in Africa, where the healthcare system is not developed as in other countries.

monkeypox virus
In the picture: Monkeypox. Photo Credit: NIAID

Still, monkeypox could lead to severe health consequences, excruciating pain, and severe skin rash. According to the CDC, monkeypox spreads mostly through skin-to-skin contact. It could also spread through close contact with someone or an object infected.

The high number of cases could also lead to another danger: monkeypox variants. Similar to what happened with COVID, variants might accelerate how the virus spreads and lead to a severe increase in the number of cases.


RELATED ARTICLES: ‘Still so Many Unknowns’: An Unprecedented Outbreak of Monkeypox | Dealing With Infectious Disease Outbreaks: Up to the Job? | Political Polarization in America: The Way Forward? |

But there is again good news here. Monkeypox vaccines do exist and smallpox vaccines seem to be effective as well.

Yet the US government seems to have acted too slowly. Declaring now monkeypox a national health emergency will help deliver vaccines to those more at risk however it might be too late to contain the virus.

With over 7,000 cases reported last week in the US – 25,000 global – there are serious concerns that monkeypox will keep spreading. Having two dangerous viruses circulating at the same time does not seem like an ideal scenario.

https://www.tiktok.com/@jmatthiasford/video/7113735791133658410?_t=8TW9CCEw2fe&_r=1

The US congress has not voted yet on the last COVID response request and will now have to approve at least a $ 7 billion budget to contain this other virus.

As a UN official recently pointed out, there have been several monkeypox outbreaks in the past in Africa, but until this had become a northern problem no one took action. With only just over 300,000 doses of vaccines available in the US and over 1,5 million people potentially at risk in the country, it looks like the country is not prepared to fight the virus.

Pandemic preparedness is what most of the countries across the world failed at during the first COVID wave. Hopefully, we are not heading in that direction again and it will still be possible to contain monkeypox. The next few weeks will be crucial.


Editor’s Note: The opinions expressed here by Impakter.com columnists are their own, not those of Impakter.com –In the Featured Photo: The effects of monkeypox on human skin. Photo credit: Wikipedia.

Share: Facebook X LinkedIn
Tags: Healthcaremonkeypoxpandemicvirus
Previous Post

Eco-Vacation: Top Kid-Friendly Ideas

Next Post

5 Cities, 5 Ways to Make Urban Mobility More Sustainable and More Equitable

Related Posts

Ajay S. Banga
Politics & Foreign Affairs

Is Ajay Banga the Leader the World Bank Needs? No.

May 1, 2026
United Nations General Assembly Hall in the UN Headquarters
Politics & Foreign Affairs

Peace First: Why the Next UN Secretary-General Must Recenter the Organization on Its Founding Purpose

April 30, 2026
People fleeing the military offensive in Ukraine
Editors' Picks

The Small Country Paradox: New Migration Report Exposes the Fault Lines of EU Burden Sharing

April 29, 2026
Next Post
5 Cities, 5 Ways to Make Urban Mobility More Sustainable and More Equitable

5 Cities, 5 Ways to Make Urban Mobility More Sustainable and More Equitable

Related News

ESG news on Russia filling in Syria’s energy gap, India turning to biogas to fill LPG gap, Solaria Energia raising €300Million for “ready-to-made” data centre package, and INEOS Enterprises selling one of its chemical plants.

Russia to Fill Syria’s Energy Gap

May 1, 2026
Ajay S. Banga

Is Ajay Banga the Leader the World Bank Needs? No.

May 1, 2026

Impakter informs you through the ESG news site and empowers your business CSRD compliance and ESG compliance with its Klimado SaaS ESG assessment tool marketplace that can be found on: www.klimado.com

Registered Office Address

Klimado GmbH
Niddastrasse 63,

60329, Frankfurt am Main, Germany


IMPAKTER is a Klimado GmbH website

Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).


Office Hours - Monday to Friday

9.30am - 5.00pm CEST


Email

stories [at] impakter.com

By Audience

  • TECH
    • Start-up
    • AI & MACHINE LEARNING
    • Green Tech
  • ENVIRONMENT
    • Biodiversity
    • Energy
    • Circular Economy
    • Climate Change
  • INDUSTRY NEWS
    • Entertainment
    • Food and Agriculture
    • Health
    • Politics & Foreign Affairs
    • Philanthropy
    • Science
    • Sport
    • Editorial Series

ESG/Finance Daily

  • ESG News
  • Sustainable Finance
  • Business

About Us

  • Team
  • Partners
  • Write for Impakter
  • Contact Us
  • Privacy Policy

© 2026 IMPAKTER. All rights reserved.

No Result
View All Result
  • Environment
    • Biodiversity
    • Climate Change
    • Circular Economy
    • Energy
  • FINANCE
    • ESG News
    • Sustainable Finance
    • Business
  • TECH
    • Start-up
    • AI & Machine Learning
    • Green Tech
  • Industry News
    • Entertainment
    • Food and Agriculture
    • Health
    • Politics & Foreign Affairs
    • Philanthropy
    • Science
    • Sport
  • Editorial Series
    • SDGs Series
    • Shape Your Future
    • Sustainable Cities
      • Copenhagen
      • San Francisco
      • Seattle
      • Sydney
  • About us
    • Our Story
    • Team
    • Partners
    • Write for Impakter
    • Contact Us
    • Privacy Policy

© 2026 IMPAKTER. All rights reserved.